Vir Biotechnology, Inc. (NASDAQ:VIR) presented initial Phase 1 data from two of its dual-masked T-cell engagers (TCEs): VIR-5818, which targets a variety of HER2-expressing solid tumors, and VIR-5500, ...
Morgan Stanley closed $12.79 short of its 52-week high ($136.24), which the company achieved on November 25th.
Investment bankers are gearing up for a pickup in dealmaking activity in global equity capital markets this year, buoyed by a ...
Fintel reports that on January 10, 2025, Morgan Stanley initiated coverage of Permian Resources (NYSE:PR) with a Overweight ...
Fintel reports that on January 10, 2025, Morgan Stanley initiated coverage of Chord Energy (NasdaqGS:CHRD) with a ...
Palantir (PLTR) stock is sliding for a fourth consecutive trading session, with the shares giving back about 4%, after yet ...
AMD’s AI advancements are overshadowed by Nvidia’s CUDA. Find out why AMD stock is overvalued, while NVDA continues to lead ...
While Palantir Technologies stock (NASDAQ: PLTR) had a stellar 2024, with its stock rising by about 4x, driven by the market ...
Privately held Calpine is held by owners including Bridgepoint's (UK:BPT) ECP, the Canada Pension Plan Investments and Access Industries, which have agreed to an 18-month lock-up of Constellation ...
SoFi Technologies (NASDAQ: SOFI) made its public debut on June 1, 2021, through a merger with a special purpose acquisition ...
Oklahoma-based financial advisors John “David” Veitch and his son Drew are joining Raymond James’ employee advisor channel, ...
Morgan Stanley is a buy on weakness with strong dividend growth and projected revenue growth in Q4 2024 and early 2025. Click for our MS earnings preview.